{"title":"Vasculature alteration of foveal zone in systemic lupus erythematosus: a Meta-analysis.","authors":"Xing-Yu He, Wei-Wei Chen, Qian Wang","doi":"10.18240/ijo.2025.07.22","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To summarize and quantitatively evaluate vasculature alteration of foveal zone in systemic lupus erythematosus (SLE) patients by secondary literature analysis.</p><p><strong>Methods: </strong>A systematic search of PubMed, Embase, Web of Science, Cochrane Library, CBM, CNKI WanFang Data and VIP was conducted. Studies were about retinal vessel density in SLE patients from January 2000 to April 2023 and valid data were extracted. The Joanna Briggs Institute (JBI) critical appraisal checklist was used to evaluate the cross-sectional studies and prospective studies. The measurement data for combined effect size were weighted mean difference (WMD) and 95% confidence interval (CI). The heterogeneity was evaluated by <i>I<sup>2</sup></i> test. The fixed-effect model was adopted when <i>P</i>>0.1 or <i>I<sup>2</sup></i> <50%, and random-effect model was adopted in the contrary. Subgroup and sensitivity analysis were utilized to analyze the sources of heterogeneity. The publication bias was evaluated by Egger tests and funnel plots.</p><p><strong>Results: </strong>A total of 14 studies with 445 subjects and 441 healthy controls from 9 countries were enrolled and 11 studies were included in Meta-analysis. The JBI scores of studies were no less than 14 points. The Meta-analysis results indicated that mean parafoveal superficial vessel density (SVD; WMD=-1.22, 95%CI: -1.67, -0.76), mean perifoveal SVD (WMD=-1.42, 95%CI: -1.95, -0.89), mean whole SVD (WMD=-1.66, 95%CI: -2.53, -0.79), mean parafoveal deep vessel density (WMD=-1.67, 95%CI: -2.75, -0.59) and mean whole deep vessel density (WMD=-4.09, 95%CI: -7.67, -0.52) was significantly lower than the control, while mean foveal SVD (WMD=-1.71, 95%CI: -4.65, 1.24), mean foveal avascular zone (FAZ) area (WMD=0.04, 95%CI: -0.01, 0.09) and mean acircularity index (AI; WMD=0.00, 95%CI: -0.02, 0.02) were not different between SLE patients and controls. Subgroup analysis indicated that the heterogeneity in SVD was partially due to the scanning area. Ocellus or binoculus data contributed partially to the heterogeneity in parafoveal deep vessel density and FAZ area. Sensitivity analysis indicated that the results were robust after changing the analysis model except for foveal SVD and FAZ area. There was no bias in included studies except whole SVD.</p><p><strong>Conclusion: </strong>Parafoveal superficial and deep vessel density are significantly lower in SLE patients while FAZ area and AI are not different between SLE patients and the control.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 7","pages":"1375-1382"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207315/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.07.22","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To summarize and quantitatively evaluate vasculature alteration of foveal zone in systemic lupus erythematosus (SLE) patients by secondary literature analysis.
Methods: A systematic search of PubMed, Embase, Web of Science, Cochrane Library, CBM, CNKI WanFang Data and VIP was conducted. Studies were about retinal vessel density in SLE patients from January 2000 to April 2023 and valid data were extracted. The Joanna Briggs Institute (JBI) critical appraisal checklist was used to evaluate the cross-sectional studies and prospective studies. The measurement data for combined effect size were weighted mean difference (WMD) and 95% confidence interval (CI). The heterogeneity was evaluated by I2 test. The fixed-effect model was adopted when P>0.1 or I2 <50%, and random-effect model was adopted in the contrary. Subgroup and sensitivity analysis were utilized to analyze the sources of heterogeneity. The publication bias was evaluated by Egger tests and funnel plots.
Results: A total of 14 studies with 445 subjects and 441 healthy controls from 9 countries were enrolled and 11 studies were included in Meta-analysis. The JBI scores of studies were no less than 14 points. The Meta-analysis results indicated that mean parafoveal superficial vessel density (SVD; WMD=-1.22, 95%CI: -1.67, -0.76), mean perifoveal SVD (WMD=-1.42, 95%CI: -1.95, -0.89), mean whole SVD (WMD=-1.66, 95%CI: -2.53, -0.79), mean parafoveal deep vessel density (WMD=-1.67, 95%CI: -2.75, -0.59) and mean whole deep vessel density (WMD=-4.09, 95%CI: -7.67, -0.52) was significantly lower than the control, while mean foveal SVD (WMD=-1.71, 95%CI: -4.65, 1.24), mean foveal avascular zone (FAZ) area (WMD=0.04, 95%CI: -0.01, 0.09) and mean acircularity index (AI; WMD=0.00, 95%CI: -0.02, 0.02) were not different between SLE patients and controls. Subgroup analysis indicated that the heterogeneity in SVD was partially due to the scanning area. Ocellus or binoculus data contributed partially to the heterogeneity in parafoveal deep vessel density and FAZ area. Sensitivity analysis indicated that the results were robust after changing the analysis model except for foveal SVD and FAZ area. There was no bias in included studies except whole SVD.
Conclusion: Parafoveal superficial and deep vessel density are significantly lower in SLE patients while FAZ area and AI are not different between SLE patients and the control.
期刊介绍:
· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication
and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online).
This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from
WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed,
PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166.
IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific
Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO);
Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President,
Chinese Academy of Engineering.
International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of
blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of
AAO/PAAO) et al.
Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of
Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and
Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society).
Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press).
Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and
Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).
Associate Editors-in-Chief include:
Prof. Ning-Li Wang (President Elect of APAO);
Prof. Ke Yao (President of Chinese Ophthalmological Society) ;
Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ;
Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA);
Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society);
Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA);
Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA).
IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles,
both basic and clinical papers.
Instruction is Welcome Contribution is Welcome Citation is Welcome
Cooperation organization
International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.